NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Pembrolizumab 200 mg tobe administered as a 30 minute IV infusion every 21 days for 3 cycles

42Gy delivered in 3 fractions

Partial or total nephrectomy performed 9-12 weeks after first dose of Pembrolizumab